RecallDepth
Class II Ongoing

Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34

This recall is currently active, issued June 26, 2024. It was issued by Teva Pharmaceuticals Usa, Inc.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
June 4, 2024
Posted
June 26, 2024
Recall Number
D-0561-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
34,448 bottles
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent Drug

Distribution

Nationwide within the United States

Lot / Code Info

Lot #: 100047634 Exp. Date 4/2025; 35449379A, Exp. Date 7/2024

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls